{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:20:48Z","timestamp":1792441248671,"version":"4.5.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Insufficient eradication of cancer cells and survival of drug tolerant clones are major relapse driving forces. Underlying molecular mechanisms comprise activated prosurvival and antiapoptotic signaling, leading to insufficient apoptosis and drug resistance. The identification of programmed cell death pathways alternative to apoptosis opens up possibilities to antagonize apoptosis escape routes. We have earlier shown that acute lymphoblastic leukemia (ALL) harbors a distinct propensity to undergo cell death by receptor-interacting protein kinase 1 (RIPK1)\u2212dependent necroptosis, activated by small-molecule second mitochondria-derived activators of caspase (SMAC) mimetics. Despite demonstrated safety and tolerability of SMAC mimetics in clinical trials, their efficacy as single agent seems still limited, highlighting the need for combinatorial treatments. Here, we investigate so far unexplored regulatory mechanisms of necroptosis and identify targets for interference to augment the necroptotic antileukemia response. Ex vivo drug response profiling in a model of the bone marrow microenvironment reveals powerful synergy of necroptosis induction with histone deacetylase (HDAC) inhibition. Subsequent transcriptome analysis and functional in vivo CRISPR screening identify gene regulatory circuitries through the master transcription regulators specificity protein 1 (SP1), p300, and HDAC2 to drive necroptosis. Although deletion of SP1 or p300 confers resistance to necroptosis, loss of HDAC2 sensitizes cells to RIPK1-dependent cell death by SMAC mimetics. Consequently, our data inform strong in vivo antileukemic activity of combinatorial necroptosis induction and HDAC inhibition in patient-derived human leukemia models. Thus, transcriptional dependency of necroptosis activation is a key regulatory mechanism that identifies novel targets for interference, pointing out a strategy to exploit alternative nonapoptotic cell death pathways to eradicate resistant disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028938","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:44:06Z","timestamp":1747151046000},"page":"861-873","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-6385","authenticated-orcid":false,"given":"Anna","family":"Saorin","sequence":"first","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0384-5330","authenticated-orcid":false,"given":"Anna","family":"Dehler","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-4860","authenticated-orcid":false,"given":"Bartim\u00e9e","family":"Galvan","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-2212","authenticated-orcid":false,"given":"Fabio","family":"Steffen","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1672-9141","authenticated-orcid":false,"given":"Marine","family":"Ray","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lu","sequence":"additional","affiliation":[{"name":"2Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[{"name":"2Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-2569","authenticated-orcid":false,"given":"James","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Drakul","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-7854","authenticated-orcid":false,"given":"Samanta","family":"Kisele","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-7919","authenticated-orcid":false,"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"2Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX"},{"name":"3Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-6227","authenticated-orcid":false,"given":"Jean-Pierre","family":"Bourquin","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-3191","authenticated-orcid":false,"given":"Beat C.","family":"Bornhauser","sequence":"additional","affiliation":[{"name":"1Department of Oncology and Children\u2019s Research Centre, University Children\u2019s Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2025081411221644800_bib1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"16","key":"2025081411221644800_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1182\/blood.2019004043","article-title":"How I treat relapsed acute lymphoblastic leukemia in the pediatric population","volume":"136","author":"Hunger","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2025081411221644800_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/2643-3230.BCD-24-0001","article-title":"Acquired multidrug resistance in AML is caused by low apoptotic priming in relapsed myeloblasts","volume":"5","author":"Olesinski","year":"2024","journal-title":"Blood Cancer Discov"},{"issue":"23","key":"2025081411221644800_bib4","doi-asserted-by":"crossref","first-page":"e2019740118","DOI":"10.1073\/pnas.2019740118","article-title":"Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration","volume":"118","author":"S\u00e1nchez-Rivera","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"720","key":"2025081411221644800_bib5","doi-asserted-by":"crossref","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"2025081411221644800_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41435-021-00161-5","article-title":"Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma [published correction appears in Genes Immun. 2022;23(8):244]","volume":"23","author":"Decraene","year":"2022","journal-title":"Genes Immun"},{"issue":"5","key":"2025081411221644800_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6281","key":"2025081411221644800_bib8","doi-asserted-by":"crossref","first-page":"aaf2154","DOI":"10.1126\/science.aaf2154","article-title":"Programmed necrosis in inflammation: toward identification of the effector molecules","volume":"352","author":"Wallach","year":"2016","journal-title":"Science"},{"issue":"339","key":"2025081411221644800_bib9","doi-asserted-by":"crossref","first-page":"339ra70","DOI":"10.1126\/scitranslmed.aad2986","article-title":"Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL","volume":"8","author":"McComb","year":"2016","journal-title":"Sci Transl Med"},{"issue":"19","key":"2025081411221644800_bib10","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1182\/bloodadvances.2019000796","article-title":"TNFR2 is required for RIP1-dependent cell death in human leukemia","volume":"4","author":"Aguad\u00e9-Gorgori\u00f3","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2025081411221644800_bib11","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/s41467-021-23474-5","article-title":"Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance","volume":"12","author":"Garcia","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"2025081411221644800_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","article-title":"The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis","volume":"150","author":"Li","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2025081411221644800_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/cells9020406","article-title":"Future therapeutic directions for smac-mimetics","volume":"9","author":"Morrish","year":"2020","journal-title":"Cells"},{"issue":"21","key":"2025081411221644800_bib14","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood.2023022455","article-title":"Targeting the TNF\/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia","volume":"143","author":"\u00c1vila","year":"2024","journal-title":"Blood"},{"issue":"7674","key":"2025081411221644800_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours [published correction appears in Nature. 2018;558(7710):E1]","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"issue":"12","key":"2025081411221644800_bib16","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell"},{"issue":"11","key":"2025081411221644800_bib17","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1182\/blood-2016-09-738070","article-title":"Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia","volume":"129","author":"Frismantas","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2025081411221644800_bib18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41419-018-1160-2","article-title":"Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism","volume":"9","author":"Lincoln","year":"2018","journal-title":"Cell Death Dis"},{"issue":"10","key":"2025081411221644800_bib19","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"2025081411221644800_bib20","first-page":"2923","article-title":"Protein acetylation and deacetylation: an important regulatory modification in gene transcription (review)","volume":"20","author":"Xia","year":"2020","journal-title":"Exp Ther Med"},{"issue":"37","key":"2025081411221644800_bib21","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"issue":"16","key":"2025081411221644800_bib22","doi-asserted-by":"crossref","first-page":"e138560","DOI":"10.1172\/JCI138560","article-title":"Entinostat induces antitumor immune responses through immune editing of tumor neoantigens","volume":"131","author":"Truong","year":"2021","journal-title":"J Clin Invest"},{"issue":"5","key":"2025081411221644800_bib23","doi-asserted-by":"crossref","first-page":"e1006752","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Malyutina","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"2025081411221644800_bib24","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1038\/s41467-024-55006-2","article-title":"Development of a RIPK1 degrader to enhance antitumor immunity","volume":"15","author":"Yu","year":"2024","journal-title":"Nat Commun"},{"issue":"12","key":"2025081411221644800_bib25","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.3390\/ijms241210108","article-title":"The many faces of MLKL, the executor of necroptosis","volume":"24","author":"Martinez-Osorio","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2025081411221644800_bib26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41588-019-0534-4","article-title":"Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma","volume":"51","author":"Gryder","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"2025081411221644800_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2015.05.020","article-title":"Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells","volume":"366","author":"Steinwascher","year":"2015","journal-title":"Cancer Lett"},{"issue":"4","key":"2025081411221644800_bib28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/cancers15041315","article-title":"SMAC mimetics synergistically cooperate with HDAC inhibitors enhancing TNF-\u03b1 autocrine signaling","volume":"15","author":"Shibuya","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"2025081411221644800_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2025081411221644800_bib30","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.celrep.2019.07.077","article-title":"RIPK3 activation leads to cytokine synthesis that continues after loss of cell membrane integrity","volume":"28","author":"Orozco","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"2025081411221644800_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41556-017-0003-1","article-title":"ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC","volume":"20","author":"Dziedzic","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"2","key":"2025081411221644800_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/cmi.2011.59","article-title":"Regulation of NF-\u03baB signaling by the A20 deubiquitinase","volume":"9","author":"Shembade","year":"2012","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"2025081411221644800_bib33","doi-asserted-by":"crossref","first-page":"e9677","DOI":"10.15252\/msb.20209677","article-title":"An incoherent feedforward loop interprets NF\u03baB\/RelA dynamics to determine TNF-induced necroptosis decisions","volume":"16","author":"Oliver Metzig","year":"2020","journal-title":"Mol Syst Biol"},{"issue":"1","key":"2025081411221644800_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12550","article-title":"The interplay of IKK, NF-\u03baB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation","volume":"277","author":"Kondylis","year":"2017","journal-title":"Immunol Rev"},{"issue":"8","key":"2025081411221644800_bib35","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","article-title":"Histone deacetylase 1 can repress transcription by binding to Sp1","volume":"19","author":"Doetzlhofer","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"1-3","key":"2025081411221644800_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000087728","article-title":"Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1","volume":"16","author":"Kang","year":"2005","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"2025081411221644800_bib37","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1074\/jbc.M113.511444","article-title":"Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase\/natriuretic peptide receptor-A gene interactive roles of modified histones, histone acetyltransferase, p300, and Sp1","volume":"289","author":"Kumar","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"2025081411221644800_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-genet-071719-022748","article-title":"Genetic regulation of RIPK1 and necroptosis","volume":"55","author":"Xu","year":"2021","journal-title":"Annu Rev Genet"},{"issue":"1","key":"2025081411221644800_bib39","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1038\/s41467-022-35375-2","article-title":"Structural insights into p300 regulation and acetylation-dependent genome organisation","volume":"13","author":"Ibrahim","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"2025081411221644800_bib40","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1074\/jbc.274.3.1189","article-title":"Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates","volume":"274","author":"Schiltz","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"2025081411221644800_bib41","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/sj.onc.1210821","article-title":"p300 plays a role in p16INK4a expression and cell cycle arrest","volume":"27","author":"Wang","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"2025081411221644800_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1535-7163.MCT-07-2026","article-title":"MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo","volume":"7","author":"Fournel","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2025081411221644800_bib43","doi-asserted-by":"crossref","first-page":"112861","DOI":"10.1016\/j.ejmech.2020.112861","article-title":"Current development of CBP\/p300 inhibitors in the last decade","volume":"209","author":"He","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"4","key":"2025081411221644800_bib44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2016.03.008","article-title":"The public repository of xenografts enables discovery and randomized phase II-like trials in mice [published correction appears in Cancer Cell. 2016;30(1):183]","volume":"29","author":"Townsend","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"2025081411221644800_bib45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","article-title":"Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia","volume":"38","author":"Bhatt","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"2025081411221644800_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer [published correction apeears in Nat Rev Drug Discov. 2012;11(4):331]","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"2025081411221644800_bib47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6652","key":"2025081411221644800_bib48","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abn1725","article-title":"Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1","volume":"380","author":"Zhang","year":"2023","journal-title":"Science"},{"issue":"1","key":"2025081411221644800_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13058-020-01367-7","article-title":"Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer","volume":"22","author":"Lee","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"12","key":"2025081411221644800_bib50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41419-018-1257-7","article-title":"Osteocalcin triggers Fas\/FasL-mediated necroptosis in adipocytes via activation of p300","volume":"9","author":"Otani","year":"2018","journal-title":"Cell Death Dis"},{"issue":"11","key":"2025081411221644800_bib51","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-15-0475","article-title":"A phase I study of the SMAC-mimetic birinapant in adults with refractory solid tumors or lymphoma","volume":"14","author":"Amaravadi","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2025081411221644800_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bjh.14698","article-title":"A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma","volume":"178","author":"Batlevi","year":"2017","journal-title":"Br J Haematol"},{"key":"2025081411221644800_bib53","doi-asserted-by":"crossref","first-page":"578011","DOI":"10.3389\/fgene.2020.578011","article-title":"Synergistic enhancement of cancer therapy using HDAC inhibitors: opportunity for clinical trials","volume":"11","author":"Hontecillas-Prieto","year":"2020","journal-title":"Front Genet"},{"issue":"5969","key":"2025081411221644800_bib54","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.1182364","article-title":"Inhibition of NF-\u03baB signaling by A20 through disruption of ubiquitin enzyme complexes","volume":"327","author":"Shembade","year":"2010","journal-title":"Science"},{"issue":"10","key":"2025081411221644800_bib55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41419-019-1937-y","article-title":"A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms [published correction appears in Cell Death Dis. 2020;11(1):60]","volume":"10","author":"Priem","year":"2019","journal-title":"Cell Death Dis"},{"key":"2025081411221644800_bib56","doi-asserted-by":"crossref","first-page":"1159743","DOI":"10.3389\/fimmu.2023.1159743","article-title":"Targeting RIPK1 kinase for modulating inflammation in human diseases","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"2025081411221644800_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"8009","key":"2025081411221644800_bib58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41586-024-07265-8","article-title":"Necroptosis blockade prevents lung injury in severe influenza","volume":"628","author":"Gautam","year":"2024","journal-title":"Nature"},{"issue":"6663","key":"2025081411221644800_bib59","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.abp9556","article-title":"MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease","volume":"381","author":"Balusu","year":"2023","journal-title":"Science"},{"issue":"7534","key":"2025081411221644800_bib60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/7\/861\/2405867\/blood_bld-2025-028938-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/7\/861\/2405867\/blood_bld-2025-028938-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:22:30Z","timestamp":1755184950000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/7\/861\/537240\/Transcriptional-remodeling-shapes-therapeutic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028938","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,14]]},"published":{"date-parts":[[2025,8,14]]}}}